Description
Empiget-M 12.5/500mg Tablets combine Empagliflozin and Metformin to manage blood sugar levels in adults with type 2 diabetes. Empagliflozin, an SGLT-2 inhibitor, helps the kidneys remove glucose from the bloodstream, while Metformin decreases glucose production in the liver and improves insulin sensitivity. This combination is also used to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. Before starting Empiget-M, inform your doctor about any pre-existing conditions or other medications you are taking. Common side effects include urinary tract infections, increased urination, and gastrointestinal issues. If you experience severe side effects, contact your healthcare provider immediately.
Dosage/Directions
Take one tablet orally twice daily with meals. The dosage is based on your medical condition and response to treatment. Follow the dosage regimen prescribed by your doctor and do not exceed the recommended dose. Do not discontinue use without consulting your doctor.
Side Effects
Common side effects of Empiget-M 12.5/500mg Tablets include urinary tract infections, increased urination, nausea, vomiting, diarrhea, and stomach pain. Most side effects are mild and resolve on their own. However, if you experience severe or persistent side effects, seek medical attention promptly.
